Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income | ($33.6K) | $0.0 | ($41.0K) | ($20.5K) | ($23.6K) | ($22.4K) | ($22.8K) | ($17.5M) | ($16.6M) | ($21.4M) | ($11.2M) | ($22.6M) | ($2,549.0K) | ($111.2M) | ($59.0M) | ($71.9M) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Aadi Bioscience, Inc.'s last 12-month Operating Income is ($66.2M), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Aadi Bioscience, Inc.'s Operating Income growth was (5.0%). The average annual Operating Income growth rates for Aadi Bioscience, Inc. have been 161.4% over the past three years, 19.1% over the past five years.
Over the last year, Aadi Bioscience, Inc.'s Operating Income growth was (5.0%), which is lower than industry growth of (0.1%). It indicates that Aadi Bioscience, Inc.'s Operating Income growth is Bad.